Columbia Labs
This article was originally published in The Tan Sheet
Executive Summary
Licenses rights to Replens and Feminesse products in the U.K. to Unipath, a division of Unilever. The deal includes "up-front payments for the products" to Columbia Labs and an exclusive supply agreement on future sales, Columbia said. The company also will receive additional payments if further indications are cleared by British health authorities. In the U.K., Replens is sold to treat vaginal dryness and Feminesse is marketed for the prevention of vaginal odor
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning